Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 5:2:58.
doi: 10.3389/fgene.2011.00058. eCollection 2011.

MicroRNA Control of Invasion and Metastasis Pathways

Rahul Sreekumar  1 , Berna S Sayan, Alex H Mirnezami, A Emre Sayan
Affiliations

MicroRNA Control of Invasion and Metastasis Pathways

Rahul Sreekumar et al. Front Genet. .

Abstract

Despite recent advances, cancer remains a leading cause of death worldwide. In developed countries, the incidence of colorectal and breast cancer has been stable, but no improvement in prognosis has been observed if the patient presents with metastases at diagnosis. This fact highlights the importance of therapeutic approaches targeting cellular invasion and metastasis programs as the next step in cancer treatment. During carcinoma progression a process called epithelial-mesenchymal transition (EMT) results in enhanced invasion and motility which is directly linked with loss of epithelial polarity and epithelial junctions, migration permissive cytoskeleton alterations, and the acquisition of mesenchymal properties. The recent discovery of microRNAs (miRNAs) controlling key cellular pathways has opened a new era in understanding how EMT pathways are modulated. In this review, we classify EMT regulating proteins according to their cellular localization (membrane, cytoplasmic, and nuclear), and summarize the current knowledge on how they are controlled by miRNAs and propose potential miRNAs for the transcripts that may control their expression.

Keywords: EMT; invasion; metastasis; microRNA; prognosis.

PubMed Disclaimer

References

    1. Ansieau S., Bastid J., Doreau A., Morel A. P., Bouchet B. P., Thomas C., Fauvet F., Puisieux I., Doglioni C., Piccinin S., Maestro R., Voeltzel T., Selmi A., Valsesia-Wittmann S., Caron de Fromentel C., Puisieux A. (2008). Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14, 79–89 10.1016/j.ccr.2008.06.005 - DOI - PubMed
    1. Ansieau S., Morel A. P., Hinkal G., Bastid J., Puisieux A. (2010). TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29, 3173–3184 10.1038/onc.2010.92 - DOI - PubMed
    1. Avizienyte E., Frame M. C. (2005). Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr. Opin. Cell Biol. 17, 542–547 10.1016/j.ceb.2005.08.007 - DOI - PubMed
    1. Bartel D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 10.1016/j.cell.2009.01.002 - DOI - PMC - PubMed
    1. Bartels C. L., Tsongalis G. J. (2009). MicroRNAs: novel biomarkers for human cancer. Clin. Chem. 55, 623–631 10.1373/clinchem.2008.112805 - DOI - PubMed

LinkOut - more resources